Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022

Detalles Bibliográficos
Autores principales: Klein, Nicola P., Stockwell, Melissa S., Demarco, Maria, Gaglani, Manjusha, Kharbanda, Anupam B., Irving, Stephanie A., Rao, Suchitra, Grannis, Shaun J., Dascomb, Kristin, Murthy, Kempapura, Rowley, Elizabeth A., Dalton, Alexandra F., DeSilva, Malini B., Dixon, Brian E., Natarajan, Karthik, Stenehjem, Edward, Naleway, Allison L., Lewis, Ned, Ong, Toan C., Patel, Palak, Konatham, Deepika, Embi, Peter J., Reese, Sarah E., Han, Jungmi, Grisel, Nancy, Goddard, Kristin, Barron, Michelle A., Dickerson, Monica, Liao, I-Chia, Fadel, William F., Yang, Duck-Hye, Arndorfer, Julie, Fireman, Bruce, Griggs, Eric P., Valvi, Nimish R., Hallowell, Carly, Zerbo, Ousseny, Reynolds, Sue, Ferdinands, Jill, Wondimu, Mehiret H., Williams, Jeremiah, Bozio, Catherine H., Link-Gelles, Ruth, Azziz-Baumgartner, Eduardo, Schrag, Stephanie J., Thompson, Mark G., Verani, Jennifer R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Full Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893336/
https://www.ncbi.nlm.nih.gov/pubmed/35239634
http://dx.doi.org/10.15585/mmwr.mm7109e3
Descripción
Sumario:

Ejemplares similares